ACQUIREDT+7
Krempa David
Eton Pharmaceuticals Inc · NASDAQ
+10,522 sh
Filed 6 Oct 2026SEC Form 4view source
Renaissance Technologies
13F filer
$4.0M
163,321 sh
Two Sigma Investments
13F filer
$2.6M
106,393 sh
Polen Capital Management
13F filer
$1.6M
45,379 sh
BlackRock
13F filer
$929.1K
282,389 sh
Krempa David
US insider
$229.4K
6,356 sh
Maier Paul V
US insider
$7.9K
12,500 sh
Krempa David
Eton Pharmaceuticals Inc · NASDAQ
+10,522 sh
Krempa David
Eton Pharmaceuticals Inc · NASDAQ
−4,166 sh · $229.4K
Maier Paul V
Eton Pharmaceuticals Inc · NASDAQ
+50,000 sh · $189.0K
Maier Paul V
Eton Pharmaceuticals Inc · NASDAQ
−36,387 sh · $2.1M
Maier Paul V
Eton Pharmaceuticals Inc · NASDAQ
−13,485 sh · $811.9K
Maier Paul V
Eton Pharmaceuticals Inc · NASDAQ
+12,500 sh · $91.4K
Maier Paul V
Eton Pharmaceuticals Inc · NASDAQ
−128 sh · $7.9K
Krempa David
Eton Pharmaceuticals Inc · NASDAQ
+25,000 sh · $182.8K
Krempa David
Eton Pharmaceuticals Inc · NASDAQ
−25,000 sh · $1.6M
Brynjelsen Sean
Eton Pharmaceuticals Inc · NASDAQ
−7,342 sh · $456.1K